These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 39205192)
1. Assay Development and Validation for Innovative Antiviral Development Targeting the N-Terminal Autoprocessing of SARS-CoV-2 Main Protease Precursors. Huang L; Gish M; Boehlke J; Jeep RH; Chen C Viruses; 2024 Jul; 16(8):. PubMed ID: 39205192 [TBL] [Abstract][Full Text] [Related]
2. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL Roe MK; Junod NA; Young AR; Beachboard DC; Stobart CC J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33507143 [TBL] [Abstract][Full Text] [Related]
3. Apigenin analogues as SARS-CoV-2 main protease inhibitors: Farhat A; Ben Hlima H; Khemakhem B; Ben Halima Y; Michaud P; Abdelkafi S; Fendri I Bioengineered; 2022 Feb; 13(2):3350-3361. PubMed ID: 35048792 [TBL] [Abstract][Full Text] [Related]
5. An Updated Review on SARS-CoV-2 Main Proteinase (M Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 M Rut W; Groborz K; Zhang L; Sun X; Zmudzinski M; Pawlik B; Wang X; Jochmans D; Neyts J; Młynarski W; Hilgenfeld R; Drag M Nat Chem Biol; 2021 Feb; 17(2):222-228. PubMed ID: 33093684 [TBL] [Abstract][Full Text] [Related]
7. Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation. Padhi AK; Tripathi T Biochem Biophys Res Commun; 2021 May; 555():147-153. PubMed ID: 33813274 [TBL] [Abstract][Full Text] [Related]
8. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay. Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646 [TBL] [Abstract][Full Text] [Related]
9. Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study. Uzuner U; Akkus E; Kocak A; Çelik Uzuner S J Biomol Struct Dyn; 2024 Aug; 42(13):6892-6903. PubMed ID: 37458994 [TBL] [Abstract][Full Text] [Related]
10. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro). Rothan HA; Teoh TC Mol Biotechnol; 2021 Mar; 63(3):240-248. PubMed ID: 33464543 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors. Breidenbach J; Lemke C; Pillaiyar T; Schäkel L; Al Hamwi G; Diett M; Gedschold R; Geiger N; Lopez V; Mirza S; Namasivayam V; Schiedel AC; Sylvester K; Thimm D; Vielmuth C; Phuong Vu L; Zyulina M; Bodem J; Gütschow M; Müller CE Angew Chem Int Ed Engl; 2021 Apr; 60(18):10423-10429. PubMed ID: 33655614 [TBL] [Abstract][Full Text] [Related]
12. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins. Muramatsu T; Kim YT; Nishii W; Terada T; Shirouzu M; Yokoyama S FEBS J; 2013 May; 280(9):2002-13. PubMed ID: 23452147 [TBL] [Abstract][Full Text] [Related]
14. Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL Cesar Ramos de Jesus H; Solis N; Machado Y; Pablos I; Bell PA; Kappelhoff R; Grin PM; Sorgi CA; Butler GS; Overall CM J Virol; 2024 Jun; 98(6):e0004924. PubMed ID: 38742901 [TBL] [Abstract][Full Text] [Related]
15. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by Bhowmick S; Mistri TK; Khan MR; Patil PC; Busquets R; Ashif Ikbal AM; Choudhury A; Roy DK; Palit P; Saha A J Biomol Struct Dyn; 2024 Sep; 42(14):7107-7127. PubMed ID: 37482789 [TBL] [Abstract][Full Text] [Related]
16. Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform. Kenward C; Vuckovic M; Paetzel M; Strynadka NCJ J Biol Chem; 2024 Jun; 300(6):107367. PubMed ID: 38750796 [TBL] [Abstract][Full Text] [Related]
17. Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics. Alhadrami HA; Sayed AM; Sharif AM; Azhar EI; Rateb ME Molecules; 2021 May; 26(9):. PubMed ID: 34062737 [TBL] [Abstract][Full Text] [Related]
18. Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL Rawson JMO; Duchon A; Nikolaitchik OA; Pathak VK; Hu WS Viruses; 2021 Jan; 13(2):. PubMed ID: 33498923 [TBL] [Abstract][Full Text] [Related]